Quick Answer
RetinalGenix Technologies Inc. reported Stockholders Equity of -$1.46 million for fiscal year 2024.
RetinalGenix Technologies Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$1.46M | -4.1% |
| 2023 | -$1.41M | -31.5% |
| 2022 | -$1.07M | -130.1% |
| 2021 | -$464.7K | -478.3% |
| 2020 | -$80.4K | -432.5% |
| 2019 | $24.2K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$2.17M | -17.2% | -9.7% |
| June 30, 2025 | -$1.98M | -9.4% | -18.8% |
| March 31, 2025 | -$1.67M | -9.8% | -14.0% |
| December 31, 2024 | -$1.46M | -4.1% | +21.1% |
| September 30, 2024 | -$1.85M | -71.3% | -2.4% |
| June 30, 2024 | -$1.81M | -2.1% | -19.3% |
| March 31, 2024 | -$1.52M | -1.2% | -8.0% |
| December 31, 2023 | -$1.41M | -31.5% | -29.8% |
- RetinalGenix Technologies Inc. showed a decrease of -4.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2024 period, RetinalGenix Technologies Inc.’s stockholders equity has declined by 6152.8% (from $24.2 thousand to -$1.46 million).
- The most recent figure is from RetinalGenix Technologies Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 31, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: